Clinical trials test the safety of stem-cell therapy for Parkinson’s disease Both studies, which are reporting the results of early-stage clinical trials, show that the interventions were safe ...

iPSCs have the same properties as embryonic stem cells, and therefore self-renew and can differentiate into all cell types of the body except for cells in extra-embryonic tissues such as the placenta.

These cells share important molecular and functional characteristics with neural stem cells of the brain. Peripheral neural stem cells have the same cell morphology, self-renewal and differentiation ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson’s disease. The papers, published in Nature, investigate the use of cells derived from human ...

To retrieve the sperm, a sliver of tissue is cut away from the skin—a less invasive procedure than the stem cell transplant, which requires opening up the testis. When Orwig’s team first ...

Throne’s approach, however, uses its Stem Cell Educator (SCE) therapy. This deploys Cord Blood Stem Cells (CB-SCs) to recruit the patient’s own immune system, repairing and resetting that ...

"This is the first stem cell trial in the cornea in the U.S., and is paving the way for further treatments of this sort," Jurkunas told ABC News. When the cells are depleted in the cornea ...

In the first clinical study of its kind, researchers at Tokyo's Keio University have developed a stem cell treatment that they say allowed a paralyzed man to stand on his own again following a ...

TOKYO: A stem cell treat­ment helped improve the motor function of two out of four patients with a spinal cord injury in the first clinical study of its kind, Japanese scientists said.